TRANSCRIPTOME ANALYSES REVEAL NEW MARKERS FOR THE DIAGNOSIS AND TREATMENT OF KMT2A (MLL)-REARRANGED LEUKEMIA
BA Lopesa,α, CP Poubela,α, CE Teixeirab, A Caye-Eudec, H Cavéc, C Meyerd, R Marschalekd, M Boronib, M Emerencianoa
a Acute Leukemia RioSearch Group, Division of Clinical Research, Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil
b Bioinformatics and Computational Biology Laboratory, Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil
c Department of Genetics, AP-HP Robert Debré, Paris Diderot University, Paris, France
d DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt, Germany
Read
1890
Timeswas read the article
820
Total PDF
1070
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 2 | 1 | 3 |
| 2025 6 | 31 | 15 | 46 |
| 2025 5 | 31 | 15 | 46 |
| 2025 4 | 25 | 13 | 38 |
| 2025 3 | 39 | 14 | 53 |
| 2025 2 | 23 | 18 | 41 |
| 2025 1 | 29 | 16 | 45 |
| 2024 12 | 28 | 16 | 44 |
| 2024 11 | 38 | 24 | 62 |
| 2024 10 | 24 | 23 | 47 |
| 2024 9 | 32 | 20 | 52 |
| 2024 8 | 30 | 36 | 66 |
| 2024 7 | 24 | 22 | 46 |
| 2024 6 | 27 | 29 | 56 |
| 2024 5 | 27 | 25 | 52 |
| 2024 4 | 26 | 15 | 41 |
| 2024 3 | 33 | 19 | 52 |
| 2024 2 | 29 | 18 | 47 |
| 2024 1 | 24 | 20 | 44 |
| 2023 12 | 17 | 16 | 33 |
| 2023 11 | 32 | 23 | 55 |
| 2023 10 | 32 | 28 | 60 |
| 2023 9 | 24 | 25 | 49 |
| 2023 8 | 22 | 23 | 45 |
| 2023 7 | 21 | 6 | 27 |
| 2023 6 | 29 | 13 | 42 |
| 2023 5 | 26 | 14 | 40 |
| 2023 4 | 12 | 4 | 16 |
| 2023 3 | 16 | 13 | 29 |
| 2023 2 | 15 | 17 | 32 |
| 2023 1 | 17 | 4 | 21 |
| 2022 12 | 22 | 16 | 38 |
| 2022 11 | 32 | 27 | 59 |
| 2022 10 | 31 | 18 | 49 |
| 2022 9 | 23 | 21 | 44 |
| 2022 8 | 25 | 21 | 46 |
| 2022 7 | 26 | 20 | 46 |
| 2022 6 | 16 | 20 | 36 |
| 2022 5 | 17 | 21 | 38 |
| 2022 4 | 19 | 23 | 42 |
| 2022 3 | 16 | 15 | 31 |
| 2022 2 | 14 | 16 | 30 |
| 2022 1 | 15 | 17 | 32 |
| 2021 12 | 11 | 14 | 25 |
| 2021 11 | 11 | 18 | 29 |
| 2021 10 | 7 | 8 | 15 |
Show all
